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Abstract Article Info 
Introduction: NPC is a highly prevalent malignant disease in endemic regions such as Southeast Asia. Until 
now, most NPC patients have bben diagnosed in advanced stages. Early-stage NPC is difficult to diagnose 
clinically. The study present a case of early-stage NPC with the symptoms of progressive ringing in the ear. 
Case report: A 56 years old male presented with two months history of progressive unilateral ringing in the ear. 
The patient had been previously diagnosed and treated for Eustachian tube dysfunction. Endoscopic examination 
of nasopharynx showed a mass in the left fossae of Rosenmüller. CT scan depicted soft tissue thickening on the 
left side of the nasopharynx. Nasopharyngeal histopathology revealed a non-keratinizing squamous cell 
carcinoma. The patient underwent radiotherapy and up to date, no complaints have been encountered. 
Conclusion: Early detection of NPC will improve patient’s prognosis. 
Keywords:  
Nasopharyngeal carcinoma, early-stage, ear-related 
symptoms, early detection 
   
 *Corresponding author:  
Address: Otorhinolaryngology Head and Neck 
Surgery Department, Faculty of Medicine, 
Universitas Sumatera Utara, Indonesia 
 
e-mail: izrynaomi@gmail.com 
 
1. CASE REPORT 
In August 8, 2013, a 56 years old Bataknese male presented to the 
outpatient clinic of ENT Department of General Hospital of H. Adam 
Malik, Medan with two months history of progressive unilateral ringing 
in the ear. There were associated hearing impairment and feeling of 
fullness in the ipsilateral ear, but no otalgia, no ear discharge, and no 
balance disorders.  Nasal blockage and post nasal drip were experienced 
sometimes, but there were no nasal discharge and epistaxis. Throat 
problems and neuro-ophthalmic symptoms were denied. There were no 
complains of neck swelling. A history suggesting exposure to 
carcinogens was denied. The patient has been previously diagnosed and 
treated for Eustachian tube dysfunction in another hospital, but there 
was no improvement. 
Routine ENT examination revealed a dull left tympanic membrane with 
loss of light reflex. No abnormalities were found in the contralateral ear. 
Anterior nasal and oropharyngeal examinations revealed normal findings. 
However, endoscopic examination of nasopharynx showed a mass in the left 
fossae of Rosenmüller which can be seen through the left nasal cavity. 
 
Picture 1.  An endoscopic feature of nasopharyngeal carcinoma in the patient 
  
A nasopharyngeal biopsy was performed. The histopathology result 
revealed a non-keratinizing squamous cell carcinoma. Computerized axial 
tomogram (CT-scan) of the nasopharynx with contrast was ordered to 
determine tumor extensions. The CT scan revealed soft tissue thickening on 
the left side of the nasopharynx, the left fat plane was partly obliterated and no 
lymph node enlargement. Thorax x-ray, abdominal ultrasonography, and bone 
scan showed no further metastases. 
 
Picture 2. Computed tomography of the nasopharynx. 
   
The patient was diagnosed with nasopharyngeal carcinoma stage I 
(T1N0M0) and prepared for radiotherapy in September 2013. The patient 
underwent radiotherapy for 35 fractions for a total dose of 70 Gy. A follow 
up of the patient a month after the treatment indicates no significant 
symptoms. No mass to be found in the endoscopic examination despite 
the surface nasopharyngeal mucosal irregularity. 
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Picture 3. An endoscopic feature of the patient’s nasopharynx a 
month after the treatment. 
 
2. DISCUSSION 
Nasopharyngeal carcinoma (NPC) is one of the head and neck 
squamous cell carcinoma that is very common in the endemic 
geographical regions such as Southern China, Southeast Asia, Japan, and 
the Middle East/North Africa [1]. According to the International Agency 
for Research on Cancer report in 2008, nasopharyngeal cancer accounts 
for more than 80% in these regions compared to those reported in Europe 
that is only 5%. To be more specific, 71% of new nasopharyngeal cancer 
cases are reported in East and Southeast Asia, and 29% are in South and 
Central Asia and North and East Africa [2]. 
Consumption of salted fish that is related to the carcinogenic 
compound, Nitrosamine, is one of the etiologic factors most frequently 
mentioned. The consumption of salted fish at childhood contributes to the 
increased incidence. The Epstein-Barr virus (EBV) genome is frequently 
detected in the biopsy specimens of NPC. Therefore it has also been 
considered to play an oncogenic role in this tumor [3]. In this patient, history 
suggesting of exposure to carcinogens were denied. 
As for the infection of EBV, while it is very common and affecting over 
95% of the global adult population, largely asymptomatic and life-long, it is 
the undifferentiated form of (NPC) that shows the most consistent 
worldwide association with EBV [4]. This patient’s histopathology result 
revealed a non-keratinizing squamous cell carcinoma. 
Symptoms of NPC frequently present with one or more of 4 groups of 
symptoms. They are consist of: 1. Nasal symptoms such as epistaxis, nasal 
obstruction and discharge (these symptoms are related to the presence of 
tumor mass in the nasopharynx; 2. Otologic symptoms such as deafness and 
tinnitus, related to the Eustachian tube dysfunction caused by the 
lateroposterior extension of the tumor to the paranasopharyngeal space;               
3. Cranial nerve palsies, commonly 5th and 6th cranial nerves, which is 
associated with the superior extension of the tumor leading to skull base 
erosion (the patient might experience a headache, diplopia, facial pain, and 
numbness); and 4. Neck masses, usually appear in the upper neck [5]. 
Patients with an early stage of the disease may present with ear-related 
complaints. A small tumor in the fossa of Rosenmüller of the nasopharynx 
may cause Eustachian tube dysfunction. The tumor may spread outward via 
the mucosa and sub-mucosa, or along the muscle bundles within the fibro-
fatty tissue planes or the neuro-vascular planes. Tinnitus as an isolated 
symptom in the absence of other features relating to the ear is highly 
unlikely. If present, it is normally a result of the Eustachian tube, middle ear 
or auditory nerve involvement with the resulting associated aural 
manifestations as well [6]. Although a recent study showed that most 
Indonesian NPC patients had recognized the earliest sign of NPC which is 
unilateral ear problem (60.6%), data indicated that neither patients nor 
doctors gave this condition attention until cervical lymph node enlargement, 
a sign of late-stage NPC was detected [7]. 
Only 10% of NPC patients are likely to be diagnosed early at stage I [8]. 
Early-stage NPC is difficult to diagnose clinically because of its hidden 
location in the nasopharynx [9]. Furthermore, the presentations of NPC are 
variable but may also remain asymptomatic for a long time, making it harder 
to detect the occult site of presentation. Moreover, sometimes patients 
consult doctors of different specialties who have little experience in 
managing nasopharyngeal carcinoma [10].  
In this case, the patient had been experiencing two-months of 
progressive unilateral tinnitus. There was associated hearing impairment 
and feeling of fullness in the ipsilateral ear. Also, the patient has been treated 
for Eustachian tube dysfunction, but there was no improvement. A thorough 
nasoendoscopic examination and awareness of NPC early signs and 
symptoms had made it possible for us to detect an early-stage NPC.  
WHO classification of NPC in 2005 divided NPC into three major 
types. They are keratinizing squamous cell carcinoma, non-keratinizing 
carcinoma, and basaloid squamous cell carcinoma. Histopathology result, in 
this case, revealed that the tumor was a non-keratinizing squamous cell 
carcinoma. It comprises over 95% of NPC in high incidence areas and 
approximately 75-87% of NPC in low incidence areas. These types of 
tumors are generally more radiosensitive compare to squamous cell 
carcinoma and have stronger relationships with EBV [11].   
Computed tomography (CT) has long been utilized for staging NPC, 
especially to detect skull base tumor involvement with lytic or sclerotic 
lesions. However, now, in some centers, MRI has replaced the use of CT for 
primary and nodal staging. MRI is considered to be an accurate examination 
to diagnose NPC. Subclinical NPCs that are missed at endoscopy can be 
detected by MRI. NPCs in MRI usually present with intermediate signal 
intensity on T2-weighted images and low signal intensity on T1-weighted 
images. Most NPCs arise in the posterolateral recess of the pharyngeal wall 
(Rosenmüller fossa) (82%), 12% arise in the midline and 6-10% of patients 
showed normal nasopharyngeal mucosa appearance at endoscopy [12]. 
However, CT is still needed in radiotherapy planning. 
When suspicion of early-stage NPC arises, MRI can be an option if 
endoscopic examination does not reveal the expected signs. In this case, the 
CT scan revealed soft tissue thickening on the left side of the nasopharynx and 
the left fat plane was partly obliterated. No further examinations are needed.  
NPC is highly radiosensitive and radiotherapy is the mainstay of treatment 
for all stages of NPC without distant metastases with a 5-year overall survival 
of 75-90% [5, 12, 13]. For T1, N0 patients, radiotherapy alone is given with a 
radical dose of 66-70 Gy daily Monday-Friday in 6-7 weeks [14].  
The patient underwent radiotherapy for 35 fractions for a total dose of 
70 Gy. The result is satisfactory and the patient has no complaints until this 
report was made. Important prognostic factors for survival in NPC are the 
stage, WHO type, and age at diagnosis [15]. Therefore, this patient is 
expected to have good prognosis. 
 
3. CONCLUSION 
A thorough examination and awareness of NPC’s early signs and 
symptoms will made it possible for clinicians to detect an early-stage NPC. 
Stage, WHO type and age at diagnosis are important prognostic factors for 
survival for NPC patients. 
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